Wednesday, August 28, 2019 4:19:21 PM
BioLife Solutions, Inc. (BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduction tools for cell and gene therapies, today announced the hiring of two key sales executives who will assist in building and leading the worldwide sales organization. Both executives report to Jim Mathers, Vice President of Global Sales.
Marcus Schulz, Vice President, Sales, evo® Platform, is responsible for managing relationships with the leading specialty couriers serving the cell and gene therapy market to drive adoption of the evo system. He will also manage C-level relationships with strategic end-user customers. Prior to joining BioLife, Marcus served in a variety of strategic business development and executive sales leadership roles with companies including Siemens Healthcare, Johnson & Johnson, Abbott Laboratories and most recently, GE Healthcare, where he managed a $1 billion annual revenue strategic account.
Andrew Sabatier, Director of Sales, North America, is responsible for managing the North American sales team, which is promoting the entire product portfolio. Prior to joining BioLife, Andrew spent the last twenty years building and leading sales teams, including at Biosafe Group, where he drove revenue from zero to nearly $30 million prior to the acquisition of Biosafe by GE Healthcare.
Mike Rice, BioLife Solutions CEO, remarked, "Marcus and Andrew bring a wealth of C-suite sales experience and demonstrable success in driving adoption of novel technologies. I look forward to them working with Jim Mathers to accelerate sales of our growing portfolio of cell and gene therapy bioproduction tools, including biopreservation media, automated thaw technologies, and evo cold chain management solutions."
https://finance.yahoo.com/news/biolife-solutions-strengthens-sales-team-120000481.html
Recent BLFS News
- BioLife Solutions Announces the Divestiture of its Stirling Freezer Business • PR Newswire (US) • 04/18/2024 12:05:00 PM
- BioLife Solutions to Present at TD Cowen and Key Bank Investor Conferences • PR Newswire (US) • 03/04/2024 01:03:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/29/2024 09:05:54 PM
- BioLife Solutions Reports Fourth Quarter and Full Year 2023 Financial Results • PR Newswire (US) • 02/29/2024 09:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:52:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:25 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:51:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 10:50:58 PM
- BioLife Solutions to Report Fourth Quarter and Full Year 2023 Financial Results and Business Update on February 29, 2024 • PR Newswire (US) • 02/20/2024 01:03:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/02/2024 03:11:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/25/2024 10:10:38 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/24/2024 09:16:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:30:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:30:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:30:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:59 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:37 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/23/2024 10:29:24 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:42:02 PM
- BioLife Solutions Announces Preliminary Fourth Quarter and Full Year 2023 Unaudited Revenue • PR Newswire (US) • 01/08/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/04/2024 10:04:58 PM
FEATURED Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • Apr 25, 2024 8:52 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM